Suo Quan Wan
Clozapine
Taichung Veterans General HospitalPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Clozapine cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Semaglutide Anders Fink-Jensen, MD, DMSci | Phase 4 | BB |
Clozapine Ruijin Hospital | Early Phase 1 | CC |
Same molecule, other indications
Suo Quan Wan is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →